No Data
RXO Announces Participation at Upcoming Investor Conferences
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Cuts Target Price to $29
Goldman Sachs Maintains RXO Inc(RXO.US) With Hold Rating, Raises Target Price to $29
Express News | RXO Inc : BofA Global Research Cuts Price Objective to $29 From $30
SIG Maintains RXO Inc(RXO.US) With Sell Rating, Cuts Target Price to $12
RXO Shares Are Trading Lower After Citigroup Downgraded the Stock From Buy to Neutral and Maintained the Price Target From $33. Also, Susquehanna Maintained a Negative Rating on the Stock and Lowered Its Price Target From $16 to $12.